Market Closed -
Other stock markets
|
After market 20:59:28 | |||
3.394 EUR | +0.12% | 3.444 | +1.47% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Sales 2024 * | 192M 206M 16.46B | Sales 2025 * | 234M 251M 20B | Capitalization | 469M 503M 40.14B |
---|---|---|---|---|---|
Net income 2024 * | 25M 26.82M 2.14B | Net income 2025 * | -33M -35.4M -2.82B | EV / Sales 2024 * | 2.62 x |
Net Debt 2024 * | 34.49M 37M 2.95B | Net Debt 2025 * | 87.97M 94.36M 7.53B | EV / Sales 2025 * | 2.38 x |
P/E ratio 2024 * |
22.9
x | P/E ratio 2025 * |
-41
x | Employees | 676 |
Yield 2024 * |
-
| Yield 2025 * |
0.3% | Free-Float | 83.73% |
Latest transcript on Valneva
1 day | +1.59% | ||
1 week | -9.49% | ||
Current month | -3.61% | ||
1 month | -4.93% | ||
3 months | -10.19% | ||
6 months | -34.68% | ||
Current year | -28.53% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09/05/13 | |
Peter Buhler
DFI | Director of Finance/CFO | 54 | 28/07/21 |
Vincent Dequenne
COO | Chief Operating Officer | - | 05/07/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathrin Jansen
BRD | Director/Board Member | - | 20/06/23 |
James Sulat
BRD | Director/Board Member | 73 | 06/03/13 |
Jim Connolly
BRD | Director/Board Member | 59 | 23/06/22 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 3.394 | +0.12% | 3 065 |
30/04/24 | 3.39 | -2.25% | 23,174 |
29/04/24 | 3.468 | -1.31% | 8,507 |
26/04/24 | 3.514 | +0.17% | 6,368 |
25/04/24 | 3.508 | +1.10% | 3,216 |
Delayed Quote Xetra, May 02, 2024 at 04:35 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- VLA Stock
- AYJ Stock